EEOICPA Covered Illnesses

The Energy Employees Occupational Illness Compensation Program Act (EEOICPA) was enacted in October 2000. Part B of the EEOICPA compensates current or former employees (or their survivors) of the Department of Energy (DOE), its predecessor agencies, and certain of its vendors, contractors and subcontractors, who were diagnosed with a radiogenic cancer, chronic beryllium disease (CBD), beryllium sensitivity, or chronic silicosis, as a result of exposure to radiation, beryllium, or silica while employed at covered facilities. Part B also provides additional compensation to individuals (or their eligible survivors) awarded benefits by the Department of Justice (DOJ) under Section 5 of the Radiation Exposure Compensation Act (RECA).

Part E of the EEOICPA (enacted October 28, 2004) compensates DOE contractor and subcontractor employees, eligible survivors of such employees, and uranium miners, millers, and ore transporters as defined by RECA Section 5, for any illnesses that are causally linked to toxic exposures in the DOE or mining work environment.

Part B Compensable Occupational Illnesses

– Chronic Silicosis – (Workers in Nevada or Alaska during the mining of tunnels at underground nuclear weapons tests sites.)
– Beryllium Sensitivity – (No compensation is awarded; medical monitoring only.)
– Chronic Beryllium Disease
– Radiogenic Cancers to include Specified Cancers
– RECA Section 5 Specified Compensable Diseases

Part E Compensable Covered Illnesses

A Part E Covered Illness is an illness or death resulting from exposure to a toxic substance from employment at a DOE facility or a RECA section 5 facility. This includes any occupational illness accepted under Part B. That is any condition accepted under Part B of the EEOICPA will also be accepted under Part E of the EEOICPA as a covered illness. Below is a list of illnesses with a known causal link to a toxic substance. If you are diagnosed with any of these conditions you should consider our EEOICPA Liaison Services.

Radiogenic Cancers

A radiogenic cancer is any diagnosed cancer other than Chronic Lymphocytic Leukemia (CLL) that is determined to have a probability of causation of 50% or greater due to radiation exposure. If you have been diagnosed with any cancer and have covered employment under the EEOICPA you may be eligible for compensation and medical benefits. Feel free to contact our EEOICPA Liaison if you have any questions.

Specified Cancers

In addition to satisfying the employment criteria under a SEC class, the employee must have been diagnosed with a specified cancer to be eligible for compensation under the SEC provision. As with any cancer claim, the employee’s occupational exposure to radiation must be before the initial date of diagnosis. For all specified cancers, first exposure can occur at any covered facility during a covered period, and does not need to be within a SEC covered period. The following are specified cancers in accordance with 20 CFR § 30.5(ff):

– Leukemia : (CLL is Excluded. Onset is to have occurred at least 2 years after initial exposure)
– Lung Cancer Primary (P) or Secondary (S) : (Includes Sarcoma of the Lung as well as Cancer of the Trachea and Bronchi *)
– Bone Cancer (P) (S)
– Myelodysplastic syndrome
– Myelofibrosis with myeloid metaplasia
– Essential Thrombocytosis or Essential Thrombocythemia, and Primary Polycythemia Vera
– Renal Cancers (P) (S)

The following diseases, onset must have been at least fiver years after  initial exposure:

– Multiple Myeloma
– Lymphomas : (Other than Hodgkin’s Disease)
– Thyroid Cancer (P)
– Breast Cancer Mail or Female (P)
– Esophagus Cancer (P)
– Stomach Cancer (P)
– Pharynx Cancer (P) : (Includes Nasopharynx, Hypopharynx, and Oropharynx)
– Small Intestine Cancer (P)
– Pancreas Cancer (P)
– Bile Ducts Cancer (P) : (Includes Hepatopancreatic Ampulla)
– Gallbladder Cancer (P)
– Salivary Gland Cancer (P)
– Urinary Bladder Cancer (P)
– Brain Cancer (P)
– Colon Cancer (P) : (Includes Rectum and Appendix)
– Ovary Cancer (P)
– Liver Cancer (P) : (Except if Cirrhosis or Hepatitis B is indicated)

* The pleura and lung and separate organs, so cancer of the pleura, such as mesothelioma, is not a specified cancer.

RECA Section 5 Specified Diseases

– Lung Cancer
– Renal Cancer
– Chronic Renal Disease and Nephritis
– Kidney Tubal Tissue Injury
– Nonmalignant Respiratory Diseases*

* Pulmonary Fibrosis, Fibrosis of the Lung, Corpulmonale due to fibrosis of the lung, Silicosis, and Pneumoconiosis

Illnesses with a Known Causal Link to a Toxic Substance

If you have been diagnosed with a condition that is not listed below as a condition with a known causal link to a toxic substance and you have questions, please contact our EEOICPA Liaison.

– Acro-osteolysi
– Acute tubular necrosis
– Angiosarcoma of the liver
– Animal handler lung
– Aplastic anemia
– Arsenic, chronic toxic effect
– Asbestosis
– Asbestos-related pleural disease
– Asphyxiation, chemical
– Asphyxiation, simple
– Bird breeder lung
– Bladder cancer
– Bone cancer
– Bronchiolitis obliterans
– Byssinosis
– Cadmium, chronic toxic effect
– Carbon disulfide, chronic toxic effect
– Cataract, chemical or radiation induced
– Chloracne
– Chromium, chronic toxic effect
– Chromomycosis
– Chronic beryllium disease
– Chronic renal failure
– Coal workers’ pneumoconiosis
– Colorado tick fever
– Contact dermatitis, allergic
– Contact dermatitis, photoallergic
– Contact dermatitis, photoirritant
– Contact urticaria
– Cutaneous larva migrans
– CWP, complicated
– Cytomegalovirus infection
– Dermatophytosis
– Ehrlichiosis
– Encephalopathy, acute toxic
– Encephalopathy, chronic solvent
– Fumigants, acute toxic effect
– Gastroenteritis, viral
– Hantavirus pulmonary syndrome
– Hard metal disease
– Hemolytic anemia, acute
– Hemorrhagic fever with renal syndrome
– Hepatitis A
– Hepatitis B
– Hepatitis C
– Hepatitis, chemical
– Histoplasmosis
– Humidifier fever
– Humidifier HP
– Hydrofluoric acid, toxic effect
– Hypersensitivity pneumonitis
– Hypersensitivity pneumonitis, acute
– Infertility, female
– Infertility, male
– Influenza
– Inhalation fever
– Isocyanate HP
– Kidney cancer
– Laryngeal cancer
– Lead, subacute toxic effect
– Legionellosis
– Leukemia
– Liver cancer
– Lung cancer
– Lyme disease
– Lymphocytic choriomeningitis
– Lymphoma, Non-Hodgkin
– Manganese, chronic toxic effect
– Measles
– Melanoma
– Melioidosis
– Mercury, elemental, chronic toxic effect
– Mesothelioma, peritoneal
– Mesothelioma, pleural
– Metal fume fever
– Metalworking fluids HP
– Methemoglobinemia, acute
– Mill fever
– Nasal sinus cancer
– Nasopharynx cancer
– Neuropathy, toxic
– Oil acne
– Omsk hemorrhagic fever
– Orf (Contagious ecthyma)
– Organic dust inhalation fever
– Organochlorine insecticides, acute poisoning
– Organophosphate & carbamates, acute poisoning
– Osteomalacia
– Osteonecrosis
– Ovarian cancer
– Paracoccidioidomycosis
– Parkinsonism
– Parvovirus B19 infection
– Pentachlorophenol/Dinitrophenol, acute poisoning
– Pneumoconioses, benign
– Pneumoconioses, other
– Pneumonitis, toxic
– Polymer fume fever
– Pulmonary disease, chronic obstructive
– Rabies
– Radiation sickness, acute
– Rat-bite fever
– Raynaud’s phenomenon
– Relapsing fever
– Rocky mountain spotted fever
– Sequoiosis
– Silicosis, acute
– Silicosis, complicated
– Silicosis, simple
– Skeletal fluorosis
– Skin cancer
– Solvents, acute toxic effect
– Sporotrichosis
– Stomach cancer
– Suberosis
– Tick paralysis
– TMA HP
– Tuberculosis
– Varicella-zoster virus infection
– Vesicular stomatitis fever
– Viral warts
– Vocal cord dysfunction, irritant-associated
– Yellow fever